four parameter sigmoidal dose-response curve graphpad prism software version 5.04 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
four parameter sigmoidal dose-response curve graphpad prism software version 5.04
Four Parameter Sigmoidal Dose Response Curve Graphpad Prism Software Version 5.04, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/four-parameter+sigmoidal+dose%E2%80%93response+curves+graphpad+prism+5%2E04/four+parameter+sigmoidal+dose+response+curve+graphpad+prism+software+version+5+04/pmc04833097-273-44-51
Average 90 stars, based on 1 article reviews
Four Parameter Sigmoidal Dose Response Curve Graphpad Prism Software Version 5.04, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/four-parameter+sigmoidal+dose%E2%80%93response+curves+graphpad+prism+5%2E04/four+parameter+sigmoidal+dose+response+curve+graphpad+prism+software+version+5+04/pmc04833097-273-44-51
Average 90 stars, based on 1 article reviews
four parameter sigmoidal dose-response curve graphpad prism software version 5.04 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Activity Assay:Article Title: Identification of aldehyde dehydrogenase 1A1 modulators using virtual screening. Article Snippet: The highly similar aldehyde dehydrogenase isozymes (ALDH1A1 and ALDH2) have been implicated in the metabolism of toxic biogenic aldehydes such as 3,4-dihydroxyphenylacetaldehyde (DOPAL) and 4-hydroxy-2E-nonenal.. We report the down-regulation of ALDH1A1 mRNA found in substantia nigra tissue of human Parkinson’s disease (PD) samples using the Genome-Wide SpliceArrayTM (GWSATM) technology.. Since DOPAL can rapidly inactivate ALDH1A1 in vitro, we set up a DOPAL-induced ALDH1A1 inactivation assay and used this assay to demonstrate that Alda-1, a compound originally identified as an activator of ALDH2, can also activate ALDH1A1. Activation Assay:Article Title: Identification of aldehyde dehydrogenase 1A1 modulators using virtual screening. Article Snippet: The highly similar aldehyde dehydrogenase isozymes (ALDH1A1 and ALDH2) have been implicated in the metabolism of toxic biogenic aldehydes such as 3,4-dihydroxyphenylacetaldehyde (DOPAL) and 4-hydroxy-2E-nonenal.. We report the down-regulation of ALDH1A1 mRNA found in substantia nigra tissue of human Parkinson’s disease (PD) samples using the Genome-Wide SpliceArrayTM (GWSATM) technology.. Since DOPAL can rapidly inactivate ALDH1A1 in vitro, we set up a DOPAL-induced ALDH1A1 inactivation assay and used this assay to demonstrate that Alda-1, a compound originally identified as an activator of ALDH2, can also activate ALDH1A1. Inhibition:Article Title: Identification of aldehyde dehydrogenase 1A1 modulators using virtual screening. Article Snippet: The highly similar aldehyde dehydrogenase isozymes (ALDH1A1 and ALDH2) have been implicated in the metabolism of toxic biogenic aldehydes such as 3,4-dihydroxyphenylacetaldehyde (DOPAL) and 4-hydroxy-2E-nonenal.. We report the down-regulation of ALDH1A1 mRNA found in substantia nigra tissue of human Parkinson’s disease (PD) samples using the Genome-Wide SpliceArrayTM (GWSATM) technology.. Since DOPAL can rapidly inactivate ALDH1A1 in vitro, we set up a DOPAL-induced ALDH1A1 inactivation assay and used this assay to demonstrate that Alda-1, a compound originally identified as an activator of ALDH2, can also activate ALDH1A1. Concentration Assay:Article Title: Identification of aldehyde dehydrogenase 1A1 modulators using virtual screening. Article Snippet: The highly similar aldehyde dehydrogenase isozymes (ALDH1A1 and ALDH2) have been implicated in the metabolism of toxic biogenic aldehydes such as 3,4-dihydroxyphenylacetaldehyde (DOPAL) and 4-hydroxy-2E-nonenal.. We report the down-regulation of ALDH1A1 mRNA found in substantia nigra tissue of human Parkinson’s disease (PD) samples using the Genome-Wide SpliceArrayTM (GWSATM) technology.. Since DOPAL can rapidly inactivate ALDH1A1 in vitro, we set up a DOPAL-induced ALDH1A1 inactivation assay and used this assay to demonstrate that Alda-1, a compound originally identified as an activator of ALDH2, can also activate ALDH1A1. |